BioOne Complete (complete.BioOne.org) is a full-text database of 200 subscribed and open-access titles in the biological, ecological, and environmental sciences published by nonprofit societies, associations, museums, institutions, and presses.

No abstract

A survey was carried out to identify the mosquitoes inhabiting human premises in the rural locality of Maxcanú, Yucatán, Mexico. Using the Centers for Disease Control and Prevention backpack aspirators, simple random sampling was carried out inside of 101 homes during the November 2013 rainy season. A total of 1,492 specimens were collected. Three subfamilies (Anophelinae, Culicinae, and Toxorhynchitinae) and 5 species were identified: Anopheles albimanus, Aedes aegypti, Culex interrogator, Limatus durhamii, and Toxorhynchites theobaldi. The most abundant species was Cx. interrogator (74%) followed by Ae. aegypti (25%). The Chao 1 and Bootstrap species richness estimator indicated that it was possible to collect 90% of the expected species. This is the 1st time that the presence of An. albimanus, Cx. interrogator, Li. durhamii, and Tx. theobaldi has been recorded in Maxcanú.

No abstract

Attention-deficit hyperactivity disorder is a neurodevelopmental disorder diagnosed primarily in children, although it is also present in adults. Patients present inattention, impulsivity, and hyperactivity symptoms that create difficulties in their daily lives. Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms. Although generally effective and safe, pharmacological treatments have different effects among patients, including lack of response and adverse reactions. The reasons for these differences are not fully understood, but they may derive from the highly diverse etiology of ADHD. Strategies to guide optimal pharmacological treatment selection on the basis of individual patients’ physiological markers are being developed. In this review, we describe the main pharmacological ADHD treatments used and their main drawbacks. We present alternatives under study that would allow the customization of pharmacological treatments to overcome these drawbacks and achieve more reliable improvement of ADHD symptoms.